Prodeon Medical Highlights Urocross Expander System Clinical Results at AUA 2026

Clinical Trials, Studies & Reports Scientific Sessions/Conferences April 28, 2026

Prodeon Medical showcased results from the Urocross® Expander System at the AUA 2026 Annual Meeting. The system offers a minimally invasive solution for treating benign prostatic hyperplasia (BPH) without permanent implants. Clinical data indicated significant symptom relief with preserved sexual function, making it a promising first-line interventional therapy for BPH.

Prodeon at AUA 2026: Urocross Expander pivotal RCT to be presented at the plenary: 30-month data shows durable BPH relief and preserved sexual function